Intracellular complement activation—An alarm raising mechanism?

Seminars in Immunology

Volumn 38, Issue , 2018, Pages 54-62

  Reichhardt, M P ^a   Meri, S ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Adaptive immunology; C3; C3a; C5; C5a; C5aR1; C5aR2; Cellular homeostasis; Complement; Complement signaling; Inflammasome; Intracellular complement; Intracellular defense; Metabolism

Indexed keywords

C3AR PROTEIN; C5AR1 PROTEIN; C5AR2 PROTEIN; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; MEMBRANE COFACTOR PROTEIN; MEMBRANE RECEPTOR; PROTEIN; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADIPOCYTE; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; DEFENSE MECHANISM; HELPER CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; INTRACELLULAR SIGNALING; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; NONHUMAN; REVIEW; ANIMAL; CELL DIFFERENTIATION; IMMUNOLOGY; INTRACELLULAR SPACE; METABOLISM; SIGNAL TRANSDUCTION; TH1 CELL;

ANIMALS; CELL DIFFERENTIATION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNE TOLERANCE; INTRACELLULAR SPACE; SIGNAL TRANSDUCTION; TH1 CELLS;

EID: 85055457902     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2018.03.003     Document Type: Review

References (172)

1. Al-Sharif, W.Z., Sunyer, J.O., Lambris, J.D., Smith, L.C., Sea urchin coelomocytes specifically express a homologue of the complement component C3. J. Immunol. 160 (1998), 2983–2997.
2. Levashina, E.A., Moita, L.F., Blandin, S., Vriend, G., Lagueux, M., Kafatos, F.C., Conserved role of a complement-like protein in phagocytosis revealed by dsRNA knockout in cultured cells of the mosquito, Anopheles gambiae. Cell 104 (2001), 709–718.
3. Meri, S., Self-nonself discrimination by the complement system. FEBS Lett. 590 (2016), 2418–2434.
4. Meri, S., Jarva, H., Complement regulation. Vox Sang. 74:Suppl. 2 (1998), 291–302.
5. Schmidt, C.Q., Lambris, J.D., Ricklin, D., Protection of host cells by complement regulators. Immunol. Rev. 274 (2016), 152–171.
6. Morgan, B.P., Gasque, P., Extrahepatic complement biosynthesis: where when and why?. Clin. Exp. Immunol. 107 (1997), 1–7.
7. Lokki, A.I., Heikkinen-Eloranta, J., Jarva, H., Saisto, T., Lokki, M.L., Laivuori, H., Meri, S., Complement activation and regulation in preeclamptic placenta. Front. Immunol., 5, 2014, 312.
8. Reichhardt, M.P., Jarva, H., Lokki, A.I., Laivuori, H., FINNPEC study group, Vuorela, P., Loimaranta, V., Glasner, A., Siwetz, M., Huppertz, B., Meri, S., The salivary scavenger and agglutinin (SALSA) in healthy and complicated pregnancy. PLoS One, 11, 2016, e0147867.
9. Wurzner, R., Joysey, V.C., Lachmann, P.J., Complement component C7. Assessment of in vivo synthesis after liver transplantation reveals that hepatocytes do not synthesize the majority of human C7. J. Immunol. 152 (1994), 4624–4629.
10. Wirthmueller, U., Dewald, B., Thelen, M., Schafer, M.K., Stover, C., Whaley, K., North, J., Eggleton, P., Reid, K.B., Schwaeble, W.J., Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. J. Immunol. 158 (1997), 4444–4451.
11. Seyfarth, J., Garred, P., Madsen, H.O., Extra-hepatic transcription of the human mannose-binding lectin gene (mbl2) and the MBL-associated serine protease 1–3 genes. Mol. Immunol. 43 (2006), 962–971.
12. Degn, S.E., Hansen, A.G., Steffensen, R., Jacobsen, C., Jensenius, J.C., Thiel, S., MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation. J. Immunol. 183 (2009), 7371–7378.
13. Kaye, S., Lokki, A.I., Hanttu, A., Nissila, E., Heinonen, S., Hakkarainen, A., Lundbom, J., Lundbom, N., Saarinen, L., Tynninen, O., Muniandy, M., Rissanen, A., Kaprio, J., Meri, S., Pietilainen, K.H., Upregulation of early and downregulation of terminal pathway complement genes in subcutaneous adipose tissue and adipocytes in acquired obesity. Front. Immunol., 8, 2017, 545.
14. Volanakis, J.E., Transcriptional regulation of complement genes. Annu. Rev. Immunol. 13 (1995), 277–305.
15. Naughton, M.A., Botto, M., Carter, M.J., Alexander, G.J., Goldman, J.M., Walport, M.J., Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans. J. Immunol. 156 (1996), 3051–3056.
16. Morgan, B.P., The complement system: an overview. Methods Mol. Biol. 150 (2000), 1–13.
17. Cowell, R.M., Plane, J.M., Silverstein, F.S., Complement activation contributes to hypoxic-ischemic brain injury in neonatal rats. J. Neurosci. 23 (2003), 9459–9468.
18. Stevens, B., Allen, N.J., Vazquez, L.E., Howell, G.R., Christopherson, K.S., Nouri, N., Micheva, K.D., Mehalow, A.K., Huberman, A.D., Stafford, B., Sher, A., Litke, A.M., Lambris, J.D., Smith, S.J., John, S.W., Barres, B.A., The classical complement cascade mediates CNS synapse elimination. Cell 131 (2007), 1164–1178.
19. Bialas, A.R., Stevens, B., TGF-beta signaling regulates neuronal C1q expression and developmental synaptic refinement. Nat. Neurosci. 16 (2013), 1773–1782.
20. Song, D., Zhou, W., Sheerin, S.H., Sacks, S.H., Compartmental localization of complement component transcripts in the normal human kidney. Nephron 78 (1998), 15–22.
21. Andrews, P.A., Finn, J.E., Lloyd, C.M., Zhou, W., Mathieson, P.W., Sacks, S.H., Expression and tissue localization of donor-specific complement C3 synthesized in human renal allografts. Eur. J. Immunol. 25 (1995), 1087–1093.
22. Brauer, R.B., Lam, T.T., Wang, D., Horwitz, L.R., Hess, A.D., Klein, A.S., Sanfilippo, F., Baldwin, W.M. 3rd, Extrahepatic synthesis of C6 in the rat is sufficient for complement-mediated hyperacute rejection of a guinea pig cardiac xenograft. Transplantation 59 (1995), 1073–1076.
23. Friese, M.A., Hellwage, J., Jokiranta, T.S., Meri, S., Muller-Quernheim, H.J., Peter, H.H., Eibel, H., Zipfel, P.F., Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA). Clin. Exp. Immunol. 121 (2000), 406–415.
24. Pasch, M.C., Van Den Bosch, N.H., Daha, M.R., Bos, J.D., Asghar, S.S., Synthesis of complement components C3 and factor B in human keratinocytes is differentially regulated by cytokines. J. Invest. Dermatol. 114 (2000), 78–82.
25. Riihila, P., Nissinen, L., Farshchian, M., Kallajoki, M., Kivisaari, A., Meri, S., Grenman, R., Peltonen, S., Peltonen, J., Pihlajaniemi, T., Heljasvaara, R., Kahari, V.M., Complement component C3 and complement factor B promote growth of cutaneous squamous cell carcinoma. Am. J. Pathol. 187 (2017), 1186–1197.
26. Lappin, D.F., Whaley, K., Modulation of complement gene expression by glucocorticoids. Biochem. J. 280:Pt. 1 (1991), 117–123.
27. Alper, C.A., Johnson, A.M., Birtch, A.G., Moore, F.D., Human C’3: evidence for the liver as the primary site of synthesis. Science 163 (1969), 286–288.
28. Morris, K.M., Aden, D.P., Knowles, B.B., Colten, H.R., Complement biosynthesis by the human hepatoma-derived cell line HepG2. J. Clin. Invest. 70 (1982), 906–913.
29. Ng, S.C., Sodetz, J.M., Biosynthesis of C8 by hepatocytes. Differential expression and intracellular association of the alpha-gamma- and beta-subunits. J. Immunol. 139 (1987), 3021–3027.
30. Moffat, G.J., Tack, B.F., Regulation of C4b-binding protein gene expression by the acute-phase mediators tumor necrosis factor-alpha, interleukin-6, and interleukin-1. Biochemistry 31 (1992), 12376–12384.
31. Garred, P., Thiel, S., Madsen, H.O., Ryder, L.P., Jensenius, J.C., Svejgaard, A., Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations. Clin. Exp. Immunol. 90 (1992), 517–521.
32. Malhotra, R., Collectin receptor (C1q receptor): structure and function. Behring Inst. Mitt. 93 (1993), 254–261.
33. Brauer, R.B., Baldwin 3rd, W.M., Wang, D., Horwitz, L.R., Hess, A.D., Klein, A.S., Sanfilippo, F., Hepatic and extrahepatic biosynthesis of complement factor C6 in the rat. J. Immunol. 153 (1994), 3168–3176.
34. Wurzner, R., Joysey, V.C., Lachmann, P.J., Complement component C7. Assessment of in vivo synthesis after liver transplantation reveals that hepatocytes do not synthesize the majority of human C7. J. Immunol. 152 (1994), 4624–4629.
35. McCoy, R., Haviland, D.L., Molmenti, E.P., Ziambaras, T., Wetsel, R.A., Perlmutter, D.H., N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J. Exp. Med. 182 (1995), 207–217.
36. Buchner, R.R., Hugli, T.E., Ember, J.A., Morgan, E.L., Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin. J. Immunol. 155 (1995), 308–315.
37. Wetsel, R.A., Structure, function and cellular expression of complement anaphylatoxin receptors. Curr. Opin. Immunol. 7 (1995), 48–53.
38. Crass, T., Raffetseder, U., Martin, U., Grove, M., Klos, A., Kohl, J., Bautsch, W., Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. Eur. J. Immunol. 26 (1996), 1944–1950.
39. Matsushita, M., Endo, Y., Taira, S., Sato, Y., Fujita, T., Ichikawa, N., Nakata, M., Mizuochi, T., A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin. J. Biol. Chem. 271 (1996), 2448–2454.
40. Knittel, T., Fellmer, P., Neubauer, K., Kawakami, M., Grundmann, A., Ramadori, G., The complement-activating protease P100 is expressed by hepatocytes and is induced by IL-6 in vitro and during the acute phase reaction in vivo. Lab. Invest. 77 (1997), 221–230.
41. Akaiwa, M., Yae, Y., Sugimoto, R., Suzuki, S.O., Iwaki, T., Izuhara, K., Hamasaki, N., Hakata antigen a new member of the ficolin/opsonin p35 family, is a novel human lectin secreted into bronchus/alveolus and bile. J. Histochem. Cytochem. 47 (1999), 777–786.
42. Ohtani, K., Suzuki, Y., Eda, S., Kawai, T., Kase, T., Yamazaki, H., Shimada, T., Keshi, H., Sakai, Y., Fukuoh, A., Sakamoto, T., Wakamiya, N., Molecular cloning of a novel human collectin from liver (CL-L1). J. Biol. Chem. 274 (1999), 13681–13689.
43. Keshi, H., Sakamoto, T., Kawai, T., Ohtani, K., Katoh, T., Jang, S.J., Motomura, W., Yoshizaki, T., Fukuda, M., Koyama, S., Fukuzawa, J., Fukuoh, A., Yoshida, I., Suzuki, Y., Wakamiya, N., Identification and characterization of a novel human collectin CL-K1. Microbiol. Immunol. 50 (2006), 1001–1013.
44. Unterberger, C., Hanson, S., Klingenhoff, A., Oesterle, D., Frankenberger, M., Endo, Y., Matsushita, M., Fujita, T., Schwaeble, W., Weiss, E.H., Ziegler-Heitbrock, L., Stover, C., Stat3 is involved in control of MASP2 gene expression. Biochem. Biophys. Res. Commun. 364 (2007), 1022–1025.
45. Ahearn, J.M., Fearon, D.T., Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46 (1989), 183–219.
46. Pantazis, P., Kalyanaraman, V.S., Bing, D.H., Synthesis of the third component of complement (C3) by lectin-activated and HTLV-infected human T-cells. Mol. Immunol. 27 (1990), 283–289.
47. Schwaeble, W., Dippold, W.G., Schafer, M.K., Pohla, H., Jonas, D., Luttig, B., Weihe, E., Huemer, H.P., Dierich, M.P., Reid, K.B., Properdin, a positive regulator of complement activation, is expressed in human T cell lines and peripheral blood T cells. J. Immunol. 151 (1993), 2521–2528.
48. Reed, W., Roubey, R.A., Dalzell, J.G., Matteucci, B.M., Myones, B.L., Hunt, S.W. 3rd, Kolb, W.P., Ross, G.D., Synthesis of complement component C5 by human B and T lymphoblastoid cell lines. Immunogenetics 31 (1990), 145–151.
49. Tsoukas, C.D., Lambris, J.D., Expression of EBV/C3d receptors on T cells: biological significance. Immunol. Today 14 (1993), 56–59.
50. Tenner, A.J., Functional aspects of the C1q receptors. Behring Inst. Mitt. 93 (1993), 241–253.
51. Christmas, S.E., de la Mata Espinosa, C.T., Halliday, D., Buxton, C.A., Cummerson, J.A., Johnson, P.M., Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytes. Immunology 119 (2006), 522–528.
52. Liszewski, M.K., Kolev, M., Le Friec, G., Leung, M., Bertram, P.G., Fara, A.F., Subias, M., Pickering, M.C., Drouet, C., Meri, S., Arstila, T.P., Pekkarinen, P.T., Ma, M., Cope, A., Reinheckel, T., Rodriguez de Cordoba, S., Afzali, B., Atkinson, J.P., Kemper, C., Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity 39 (2013), 1143–1157.
53. Arbore, G., West, E.E., Spolski, R., Robertson, A.A.B., Klos, A., Rheinheimer, C., Dutow, P., Woodruff, T.M., Yu, Z.X., O'Neill, L.A., Coll, R.C., Sher, A., Leonard, W.J., Kohl, J., Monk, P., Cooper, M.A., Arno, M., Afzali, B., Lachmann, H.J., Cope, A.P., Mayer-Barber, K.D., Kemper, C., T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4(+) T cells. Science, 352, 2016 (aad1210).
54. Whaley, K., Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J. Exp. Med. 151 (1980), 501–516.
55. Bensa, J.C., Reboul, A., Colomb, M.G., Biosynthesis in vitro of complement subcomponents C1q, C1 s and C1 inhibitor by resting and stimulated human monocytes. Biochem. J. 216 (1983), 385–392.
56. Hetland, G., Johnson, E., Falk, R.J., Eskeland, T., Synthesis of complement components C5, C6 C7, C8 and C9 in vitro by human monocytes and assembly of the terminal complement complex. Scand. J. Immunol. 24 (1986), 421–428.
57. Lappin, D.F., Whaley, K., Interferon-induced transcriptional and post-transcriptional modulation of factor H and C4 binding-protein synthesis in human monocytes. Biochem. J. 271 (1990), 767–772.
58. Tenner, A.J., Volkin, D.B., Complement subcomponent C1q secreted by cultured human monocytes has subunit structure identical with that of serum C1q. Biochem. J. 233 (1986), 451–458.
59. Gulati, P., Lemercier, C., Guc, D., Lappin, D., Whaley, K., Regulation of the synthesis of C1 subcomponents and C1-inhibitor. Behring Inst. Mitt. 93 (1993), 196–203.
60. McPhaden, A.R., Whaley, K., Complement biosynthesis by mononuclear phagocytes. Immunol. Res. 12 (1993), 213–232.
61. Gerard, C., Gerard, N.P., C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12 (1994), 775–808.
62. Gulati, P., Guc, D., Lemercier, C., Lappin, D., Whaley, K., Expression of the components and regulatory proteins of the classical pathway of complement in normal and diseased synovium. Rheumatol. Int. 14 (1994), 13–19.
63. Schwaeble, W., Schafer, M.K., Petry, F., Fink, T., Knebel, D., Weihe, E., Loos, M., Follicular dendritic cells interdigitating cells, and cells of the monocyte-macrophage lineage are the C1q-producing sources in the spleen. Identification of specific cell types by in situ hybridization and immunohistochemical analysis. J. Immunol. 155 (1995), 4971–4978.
64. Liu, Y., Endo, Y., Iwaki, D., Nakata, M., Matsushita, M., Wada, I., Inoue, K., Munakata, M., Fujita, T., Human M-ficolin is a secretory protein that activates the lectin complement pathway. J. Immunol. 175 (2005), 3150–3156.
65. Schmaier, A.H., Smith, P.M., Colman, R.W., Platelet C1- inhibitor. A secreted alpha-granule protein. J. Clin. Invest. 75 (1985), 242–250.
66. Tedesco, F., Densen, P., Villa, M.A., Presani, G., Roncelli, L., Rosso di san Secondo, V.E., Functional C8 associated with human platelets. Clin. Exp. Immunol. 66 (1986), 472–480.
67. Devine, D.V., Rosse, W.F., Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H. Proc. Natl. Acad. Sci. U. S. A. 84 (1987), 5873–5877.
68. Houle, J.J., Leddy, J.P., Rosenfeld, S.I., Secretion of the terminal complement proteins C5-C9, by human platelets. Clin. Immunol. Immunopathol. 50 (1989), 385–393.
69. Botto, M., Lissandrini, D., Sorio, C., Walport, M.J., Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes. J. Immunol. 149 (1992), 1348–1355.
70. Maves, K.K., Weiler, J.M., Properdin: approaching four decades of research. Immunol. Res. 12 (1993), 233–243.
71. Hogasen, A.K., Wurzner, R., Abrahamsen, T.G., Dierich, M.P., Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, which may be released on stimulation. J. Immunol. 154 (1995), 4734–4740.
72. Strunk, R.C., Eidlen, D.M., Mason, R.J., Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J. Clin. Invest. 81 (1988), 1419–1426.
73. Rothman, B.L., Merrow, M., Bamba, M., Kennedy, T., Kreutzer, D.L., Biosynthesis of the third and fifth complement components by isolated human lung cells. Am. Rev. Respir. Dis. 139 (1989), 212–220.
74. Svensson, M., Aldskogius, H., Evidence for activation of the complement cascade in the hypoglossal nucleus following peripheral nerve injury. J. Neuroimmunol. 40 (1992), 99–109.
75. Barnum, S.R., Complement biosynthesis in the central nervous system. Crit. Rev. Oral Biol. Med. 6 (1995), 132–146.
76. Walker, D.G., Kim, S.U., McGeer, P.L., Complement and cytokine gene expression in cultured microglial derived from postmortem human brains. J. Neurosci. Res. 40 (1995), 478–493.
77. Al Adnani, M.S., O'Reilly, K.M., McGee, J.O., Proceedings C1q production and secretion by fibroblasts. J. Med. Microbiol., 8, 1975 (Pxix).
78. Katz, Y., Strunk, R.C., Synovial fibroblast-like cells synthesize seven proteins of the complement system. Arthritis Rheum. 31 (1988), 1365–1370.
79. Katz, Y., Strunk, R.C., Synthesis and regulation of complement protein factor H in human skin fibroblasts. J. Immunol. 141 (1988), 559–563.
80. Katz, Y., Strunk, R.C., Synthesis and regulation of C1 inhibitor in human skin fibroblasts. J. Immunol. 142 (1989), 2041–2045.
81. McNearney, T., Ballard, L., Seya, T., Atkinson, J.P., Membrane cofactor protein of complement is present on human fibroblast epithelial, and endothelial cells. J. Clin. Invest. 84 (1989), 538–545.
82. Garred, P., Hetland, G., Mollnes, T.E., Stoervold, G., Synthesis of C3, C5 C6, C7, C8, and C9 by human fibroblasts. Scand. J. Immunol. 32 (1990), 555–560.
83. Warren, H.B., Pantazis, P., Davies, P.F., The third component of complement is transcribed and secreted by cultured human endothelial cells. Am. J. Pathol. 129 (1987), 9–13.
84. Ripoche, J., Mitchell, J.A., Erdei, A., Madin, C., Moffatt, B., Mokoena, T., Gordon, S., Sim, R.B., Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture. J. Exp. Med. 168 (1988), 1917–1922.
85. Brooimans, R.A., Hiemstra, P.S., van der Ark, A.A., Sim, R.B., van Es, L.A., Daha, M.R., Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-gamma. J. Immunol. 142 (1989), 2024–2030.
86. Oglesby, T.J., Longwith, J.E., Huettner, P.C., Human complement regulator expression by the normal female reproductive tract. Anat. Rec. 246 (1996), 78–86.
87. Ohtani, K., Suzuki, Y., Eda, S., Kawai, T., Kase, T., Keshi, H., Sakai, Y., Fukuoh, A., Sakamoto, T., Itabe, H., Suzutani, T., Ogasawara, M., Yoshida, I., Wakamiya, N., The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells. J. Biol. Chem. 276 (2001), 44222–44228.
88. Morris, K.M., Colten, H.R., Bing, D.H., The first component of complement. A quantitative comparison of its biosynthesis in culture by human epithelial and mesenchymal cells. J. Exp. Med. 148 (1978), 1007–1019.
89. Sacks, S.H., Zhou, W., Pani, A., Campbell, R.D., Martin, J., Complement C3 gene expression and regulation in human glomerular epithelial cells. Immunology 79 (1993), 348–354.
90. Zhou, W., Campbell, R.D., Martin, J., Sacks, S.H., Interferon-gamma regulation of C4 gene expression in cultured human glomerular epithelial cells. Eur. J. Immunol. 23 (1993), 2477–2481.
91. Edwards, J.L., Entz, D.D., Apicella, M.A., Gonococcal phospholipase d modulates the expression and function of complement receptor 3 in primary cervical epithelial cells. Infect. Immun. 71 (2003), 6381–6391.
92. Basset-Seguin, N., Caughman, S.W., Yancey, K.B., A-431 cells and human keratinocytes synthesize and secrete the third component of complement. J. Invest. Dermatol. 95 (1990), 621–625.
93. Dovezenski, N., Billetta, R., Gigli, I., Expression and localization of proteins of the complement system in human skin. J. Clin. Invest. 90 (1992), 2000–2012.
94. Yancey, K.B., Overholser, O., Domloge-Hultsch, N., Li, L.J., Caughman, S.W., Bisalbutra, P., Human keratinocytes and A-431 cells synthesize and secrete factor B, the major zymogen protease of the alternative complement pathway. J. Invest. Dermatol. 98 (1992), 379–383.
95. Timar, K.K., Pasch, M.C., van den Bosch, N.H., Jarva, H., Junnikkala, S., Meri, S., Bos, J.D., Asghar, S.S., Human keratinocytes produce the complement inhibitor factor H: synthesis is regulated by interferon-gamma. Mol. Immunol. 43 (2006), 317–325.
96. Choy, L.N., Rosen, B.S., Spiegelman, B.M., Adipsin and an endogenous pathway of complement from adipose cells. J. Biol. Chem. 267 (1992), 12736–12741.
97. Peake, P.W., O'Grady, S., Pussell, B.A., Charlesworth, J.A., Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes. Eur. J. Clin. Invest. 27 (1997), 922–927.
98. Zhang, J., Wright, W., Bernlohr, D.A., Cushman, S.W., Chen, X., Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 292 (2007), E1433–40.
99. Poursharifi, P., Lapointe, M., Fisette, A., Lu, H., Roy, C., Munkonda, M.N., Fairlie, D.P., Cianflone, K., C5aR and C5L2 act in concert to balance immunometabolism in adipose tissue. Mol. Cell. Endocrinol. 382 (2014), 325–333.
100. Levi-Strauss, M., Mallat, M., Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation. J. Immunol. 139 (1987), 2361–2366.
101. Gasque, P., Julen, N., Ischenko, A.M., Picot, C., Mauger, C., Chauzy, C., Ripoche, J., Fontaine, M., Expression of complement components of the alternative pathway by glioma cell lines. J. Immunol. 149 (1992), 1381–1387.
102. Gasque, P., Ischenko, A., Legoedec, J., Mauger, C., Schouft, M.T., Fontaine, M., Expression of the complement classical pathway by human glioma in culture. A model for complement expression by nerve cells. J. Biol. Chem. 268 (1993), 25068–25074.
103. Gasque, P., Chan, P., Fontaine, M., Ischenko, A., Lamacz, M., Gotze, O., Morgan, B.P., Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155 (1995), 4882–4889.
104. Gasque, P., Fontaine, M., Morgan, B.P., Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J. Immunol. 154 (1995), 4726–4733.
105. Gasque, P., Chan, P., Fontaine, M., Ischenko, A., Lamacz, M., Gotze, O., Morgan, B.P., Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155 (1995), 4882–4889.
106. Gasque, P., Chan, P., Mauger, C., Schouft, M.T., Singhrao, S., Dierich, M.P., Morgan, B.P., Fontaine, M., Identification and characterization of complement C3 receptors on human astrocytes. J. Immunol. 156 (1996), 2247–2255.
107. Singhrao, S.K., Neal, J.W., Gasque, P., Morgan, B.P., Newman, G.R., Role of complement in the aetiology of Pick's disease?. J. Neuropathol. Exp. Neurol. 55 (1996), 578–593.
108. Gasque, P., Singhrao, S.K., Neal, J.W., Gotze, O., Morgan, B.P., Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150 (1997), 31–41.
109. Planas, R., Carrillo, J., Sanchez, A., de Villa, M.C., Nunez, F., Verdaguer, J., James, R.F., Pujol-Borrell, R., Vives-Pi, M., Gene expression profiles for the human pancreas and purified islets in type 1 diabetes: new findings at clinical onset and in long-standing diabetes. Clin. Exp. Immunol. 159 (2010), 23–44.
110. Anderson, D.H., Radeke, M.J., Gallo, N.B., Chapin, E.A., Johnson, P.T., Curletti, C.R., Hancox, L.S., Hu, J., Ebright, J.N., Malek, G., Hauser, M.A., Rickman, C.B., Bok, D., Hageman, G.S., Johnson, L.V., The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog. Retin. Eye Res. 29 (2010), 95–112.
111. Luo, C., Chen, M., Xu, H., Complement gene expression and regulation in mouse retina and retinal pigment epithelium/choroid. Mol. Vis. 17 (2011), 1588–1597.
112. Bradley, K., North, J., Saunders, D., Schwaeble, W., Jeziorska, M., Woolley, D.E., Whaley, K., Synthesis of classical pathway complement components by chondrocytes. Immunology 88 (1996), 648–656.
113. Ueda, Y., Nagasawa, K., Tsukamoto, H., Horiuchi, T., Nishizaka, H., Ikeda, K., Niho, Y., Production of the third and fourth component of complement (C3, C4) by smooth muscle cells. Immunology 89 (1996), 183–188.
114. Li, W., Tada, T., Miwa, T., Okada, N., Ito, J., Okada, H., Tateyama, H., Eimoto, T., mRNA expression of complement components and regulators in rat arterial smooth muscle cells. Microbiol. Immunol. 43 (1999), 585–593.
115. Liszewski, M.K., Kemper, C., Price, J.D., Atkinson, J.P., Emerging roles and new functions of CD46. Springer Semin. Immunopathol. 27 (2005), 345–358.
116. Tam, J.C., Bidgood, S.R., McEwan, W.A., James, L.C., Intracellular sensing of complement C3 activates cell autonomous immunity. Science, 345, 2014 (1256070).
117. Baudino, L., Sardini, A., Ruseva, M.M., Fossati-Jimack, L., Cook, H.T., Scott, D., Simpson, E., Botto, M., C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 1503–1508.
118. Elvington, M., Liszewski, M.K., Atkinson, J.P., Evolution of the complement system: from defense of the single cell to guardian of the intravascular space. Immunol. Rev. 274 (2016), 9–15.
119. Martin, M., Leffler, J., Smolag, K.I., Mytych, J., Bjork, A., Chaves, L.D., Alexander, J.J., Quigg, R.J., Blom, A.M., Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes. Cell Death Differ. 23 (2016), 903–911.
120. Wiggins, R.C., Giclas, P.C., Henson, P.M., Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit. J. Exp. Med. 153 (1981), 1391–1404.
121. Ekdahl, K.N., Nilsson, B., Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets. J. Immunol. 162 (1999), 7426–7433.
122. Huber-Lang, M., Sarma, J.V., Zetoune, F.S., Rittirsch, D., Neff, T.A., McGuire, S.R., Lambris, J.D., Warner, R.L., Flierl, M.A., Hoesel, L.M., Gebhard, F., Younger, J.G., Drouin, S.M., Wetsel, R.A., Ward, P.A., Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12 (2006), 682–687.
123. Amara, U., Rittirsch, D., Flierl, M., Bruckner, U., Klos, A., Gebhard, F., Lambris, J.D., Huber-Lang, M., Interaction between the coagulation and complement system. Adv. Exp. Med. Biol. 632 (2008), 71–79.
124. Frade, R., Rodrigues-Lima, F., Huang, S., Xie, K., Guillaume, N., Bar-Eli, M., Procathepsin, L., a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells. Cancer Res. 58 (1998), 2733–2736.
125. Katz, Y., Singer, L., Wetsel, R.A., Schlesinger, M., Fishelson, Z., Inherited complement C3 deficiency: a defect in C3 secretion. Eur. J. Immunol. 24 (1994), 1517–1522.
126. Singer, L., Whitehead, W.T., Akama, H., Katz, Y., Fishelson, Z., Wetsel, R.A., Inherited human complement C3 deficiency. An amino acid substitution in the beta-chain (ASP549 to ASN) impairs C3 secretion. J. Biol. Chem. 269 (1994), 28494–28499.
127. Fishelson, Z., Kozer, E., Sirhan, S., Katz, Y., Distinction between processing of normal and mutant complement C3 within human skin fibroblasts. Eur. J. Immunol. 29 (1999), 845–855.
128. Reis, E.S., Barbuto, J.A., Isaac, L., Human monocyte-derived dendritic cells are a source of several complement proteins. Inflamm. Res. 55 (2006), 179–184.
129. Ghannam, A., Pernollet, M., Fauquert, J.L., Monnier, N., Ponard, D., Villiers, M.B., Peguet-Navarro, J., Tridon, A., Lunardi, J., Gerlier, D., Drouet, C., Human C3 deficiency associated with impairments in dendritic cell differentiation memory B cells, and regulatory T cells. J. Immunol. 181 (2008), 5158–5166.
130. Bamberg, C.E., Mackay, C.R., Lee, H., Zahra, D., Jackson, J., Lim, Y.S., Whitfeld, P.L., Craig, S., Corsini, E., Lu, B., Gerard, C., Gerard, N.P., The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J. Biol. Chem. 285 (2010), 7633–7644.
131. Croker, D.E., Halai, R., Fairlie, D.P., Cooper, M.A., C5a but not C5a-des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2. Immunol. Cell Biol. 91 (2013), 625–633.
132. Li, R., Coulthard, L.G., Wu, M.C., Taylor, S.M., Woodruff, T.M., C5L2: a controversial receptor of complement anaphylatoxin C5a. FASEB J. 27 (2013), 855–864.
133. Cain, S.A., Monk, P.N., The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J. Biol. Chem. 277 (2002), 7165–7169.
134. Scola, A.M., Johswich, K.O., Morgan, B.P., Klos, A., Monk, P.N., The human complement fragment receptor C5L2, is a recycling decoy receptor. Mol. Immunol. 46 (2009), 1149–1162.
135. Croker, D.E., Halai, R., Kaeslin, G., Wende, E., Fehlhaber, B., Klos, A., Monk, P.N., Cooper, M.A., C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and beta-arrestin recruitment. Immunol. Cell Biol. 92 (2014), 631–639.
136. Riedemann, N.C., Guo, R.F., Hollmann, T.J., Gao, H., Neff, T.A., Reuben, J.S., Speyer, C.L., Sarma, J.V., Wetsel, R.A., Zetoune, F.S., Ward, P.A., Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J. 18 (2004), 370–372.
137. Cui, W., Lapointe, M., Gauvreau, D., Kalant, D., Cianflone, K., Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation. Mol. Immunol. 46 (2009), 3207–3217.
138. Van Lith, L.H., Oosterom, J., Van Elsas, A., Zaman, G.J., C5a-stimulated recruitment of beta-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2. J. Biomol. Screen. 14 (2009), 1067–1075.
139. Gao, H., Neff, T.A., Guo, R.F., Speyer, C.L., Sarma, J.V., Tomlins, S., Man, Y., Riedemann, N.C., Hoesel, L.M., Younkin, E., Zetoune, F.S., Ward, P.A., Evidence for a functional role of the second C5a receptor C5L2. FASEB J. 19 (2005), 1003–1005.
140. Rittirsch, D., Flierl, M.A., Nadeau, B.A., Day, D.E., Huber-Lang, M., Mackay, C.R., Zetoune, F.S., Gerard, N.P., Cianflone, K., Kohl, J., Gerard, C., Sarma, J.V., Ward, P.A., Functional roles for C5a receptors in sepsis. Nat. Med. 14 (2008), 551–557.
141. Phieler, J., Garcia-Martin, R., Lambris, J.D., Chavakis, T., The role of the complement system in metabolic organs and metabolic diseases. Semin. Immunol. 25 (2013), 47–53.
142. Martinez, A., Pio, R., Lopez, J., Cuttitta, F., Expression of the adrenomedullin binding protein complement factor H, in the pancreas and its physiological impact on insulin secretion. J. Endocrinol. 170 (2001), 503–511.
143. Ahren, B., Havel, P.J., Pacini, G., Cianflone, K., Acylation stimulating protein stimulates insulin secretion. Int. J. Obes. Relat. Metab. Disord. 27 (2003), 1037–1043.
144. Conroy, S.J., Abdel-Wahab, Y.H., Caraher, E.M., Byrne, P.M., Murphy, E., Nolan, J., Flatt, P.R., Newsholme, P., Evidence for complement-dependent and –independent inhibition of insulin secretion from clonal beta-cells incubated in the presence of sera of newly diagnosed IDDM patients. J. Endocrinol. 164 (2000), 139–147.
145. Hansen, T.K., Thiel, S., Knudsen, S.T., Gravholt, C.H., Christiansen, J.S., Mogensen, C.E., Poulsen, P.L., Elevated levels of mannan-binding lectin in patients with type 1 diabetes. J. Clin. Endocrinol. Metab. 88 (2003), 4857–4861.
146. Lin, M., Yin, N., Murphy, B., Medof, M.E., Segerer, S., Heeger, P.S., Schroppel, B., Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes 59 (2010), 2247–2252.
147. Ostergaard, J.A., Thiel, S., Hansen, T.K., Rasch, R., Flyvbjerg, A., Comment on: lin et al. (2010) Immune cell-derived C3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes, 59, 2247–2252. Diabetes 60 (2011), e7–e8 (author reply e9).
148. Choy, L.N., Rosen, B.S., Spiegelman, B.M., Adipsin and an endogenous pathway of complement from adipose cells. J. Biol. Chem. 267 (1992), 12736–12741.
149. Cianflone, K., Roncari, D.A., Maslowska, M., Baldo, A., Forden, J., Sniderman, A.D., Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry 33 (1994), 9489–9495.
150. Kolev, M., Dimeloe, S., Le Friec, G., Navarini, A., Arbore, G., Povoleri, G.A., Fischer, M., Belle, R., Loeliger, J., Develioglu, L., Bantug, G.R., Watson, J., Couzi, L., Afzali, B., Lavender, P., Hess, C., Kemper, C., Complement regulates nutrient influx and metabolic reprogramming during Th1 cell responses. Immunity 42 (2015), 1033–1047.
151. Hayashi, K., Jutabha, P., Endou, H., Sagara, H., Anzai, N., LAT1 is a critical transporter of essential amino acids for immune reactions in activated human T cells. J. Immunol. 191 (2013), 4080–4085.
152. Sinclair, L.V., Rolf, J., Emslie, E., Shi, Y.B., Taylor, P.M., Cantrell, D.A., Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 14 (2013), 500–508.
153. Venter, G., Oerlemans, F.T., Wijers, M., Willemse, M., Fransen, J.A., Wieringa, B., Glucose controls morphodynamics of LPS-stimulated macrophages. PLoS One, 9, 2014, e96786.
154. Strainic, M.G., Liu, J., Huang, D., An, F., Lalli, P.N., Muqim, N., Shapiro, V.S., Dubyak, G.R., Heeger, P.S., Medof, M.E., Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 28 (2008), 425–435.
155. Yang, K., Chi, H., mTOR and metabolic pathways in T cell quiescence and functional activation. Semin. Immunol. 24 (2012), 421–428.
156. Strainic, M.G., Shevach, E.M., An, F., Lin, F., Medof, M.E., Absence of signaling into CD4(+) cells via C3aR and C5aR enables autoinductive TGF-beta1 signaling and induction of Foxp3(+) regulatory T cells. Nat. Immunol. 14 (2013), 162–171.
157. Pekkarinen, P.T., Vaali, K., Junnikkala, S., Rossi, L.H., Tuovinen, H., Meri, S., Vaarala, O., Arstila, T.P., A functional complement system is required for normal T helper cell differentiation. Immunobiology 216 (2011), 737–743.
158. Pekkarinen, P.T., Vaali, K., Jarva, H., Kekalainen, E., Hetemaki, I., Junnikkala, S., Helminen, M., Vaarala, O., Meri, S., Arstila, T.P., Impaired intestinal tolerance in the absence of a functional complement system. J. Allergy Clin. Immunol. 131 (2013), 1167–1175.
159. Hajishengallis, G., Lambris, J.D., Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol. 31 (2010), 154–163.
160. Brown, J., Wang, H., Hajishengallis, G.N., Martin, M., TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J. Dent. Res. 90 (2011), 417–427.
161. van de Veerdonk, F.L., Netea, M.G., Dinarello, C.A., Joosten, L.A., Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol. 32 (2011), 110–116.
162. van de Veerdonk, F.L., Joosten, L.A., Shaw, P.J., Smeekens, S.P., Malireddi, R.K., van der Meer, J.W., Kullberg, B.J., Netea, M.G., Kanneganti, T.D., The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis. Eur. J. Immunol. 41 (2011), 2260–2268.
163. Doni, A., Garlanda, C., Mantovani, A., Innate immunity, hemostasis and matrix remodeling: PTX3 as a link. Semin. Immunol. 28 (2016), 570–577.
164. Asgari, E., Le Friec, G., Yamamoto, H., Perucha, E., Sacks, S.S., Kohl, J., Cook, H.T., Kemper, C., C3a modulates IL-1beta secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. Blood 122 (2013), 3473–3481.
165. Samstad, E.O., Niyonzima, N., Nymo, S., Aune, M.H., Ryan, L., Bakke, S.S., Lappegard, K.T., Brekke, O.L., Lambris, J.D., Damas, J.K., Latz, E., Mollnes, T.E., Espevik, T., Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J. Immunol. 192 (2014), 2837–2845.
166. Netea, M.G., Nold-Petry, C.A., Nold, M.F., Joosten, L.A., Opitz, B., van der Meer, J.H., van de Veerdonk, F.L., Ferwerda, G., Heinhuis, B., Devesa, I., Funk, C.J., Mason, R.J., Kullberg, B.J., Rubartelli, A., van der Meer, J.W., Dinarello, C.A., Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113 (2009), 2324–2335.
167. Ferrari, D., Chiozzi, P., Falzoni, S., Dal Susino, M., Melchiorri, L., Baricordi, O.R., Di Virgilio, F., Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159 (1997), 1451–1458.
168. Ferrari, D., Chiozzi, P., Falzoni, S., Hanau, S., Di Virgilio, F., Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185 (1997), 579–582.
169. Yao, S.T., Cao, F., Chen, J.L., Chen, W., Fan, R.M., Li, G., Zeng, Y.C., Jiao, S., Xia, X.P., Han, C., Ran, Q.S., NLRP3 is required for complement-mediated caspase-1 and IL-1beta activation in ICH. J. Mol. Neurosci. 61 (2017), 385–395.
170. Doyle, S.L., Campbell, M., Ozaki, E., Salomon, R.G., Mori, A., Kenna, P.F., Farrar, G.J., Kiang, A.S., Humphries, M.M., Lavelle, E.C., O'Neill, L.A., Hollyfield, J.G., Humphries, P., NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat. Med. 18 (2012), 791–798.
171. Benoit, M.E., Clarke, E.V., Morgado, P., Fraser, D.A., Tenner, A.J., Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells. J. Immunol. 188 (2012), 5682–5693.
172. Arbore, G., Kemper, C., A novel complement-metabolism-inflammasome axis as a key regulator of immune cell effector function. Eur. J. Immunol. 46 (2016), 1563–1573.